Blood test worth $949 screens for 50 different types of cancer! Know all about it
The Galleri test, developed by Grail, screens for over 50 types of cancer with a single blood draw. Despite its potential benefits, including identifying cancers early, it faces criticism for lack of long-term evidence on reducing cancer mortality rates and its high cost. Experts recommend discussing with healthcare providers.
The Galleri test, developed by Grail, screens for over 50 types of cancer with a single blood draw. Despite its potential benefits, including identifying cancers early, it faces criticism for lack of long-term evidence on reducing cancer mortality rates and its high cost. Experts recommend discussing with healthcare providers.
